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Abstract
Background: Laboratory testing is an important clinical act with a valuable role in screening, diagnosis, management
and monitoring of diseases or therapies. However, inappropriate laboratory test ordering is frequent, burdening health
care spending and negatively influencing quality of care. Inappropriate tests may also result in false-positive results and
potentially cause excessive downstream activities. Clinical decision support systems (CDSSs) have shown promising results
to influence the test-ordering behaviour of physicians and to improve appropriateness. Order sets, a form of CDSS where a
limited set of evidence-based tests are proposed for a series of indications, integrated in a computerised physician order
entry (CPOE) have been shown to be effective in reducing the volume of ordered laboratory tests but convincing
evidence that they influence appropriateness is lacking. The aim of this study is to evaluate the effect of order sets on
the quality and quantity of laboratory test orders by physicians. We also aim to evaluate the effect of order sets on
diagnostic error and explore the effect on downstream or cascade activities.
Methods: We will conduct a cluster randomised controlled trial in Belgian primary care practices. The study is powered
to measure two outcomes. We will primarily measure the influence of our CDSS on the appropriateness of laboratory
test ordering. Additionally, we will also measure the influence on diagnostic error. We will also explore the effects of
our intervention on cascade activities due to altered results of inappropriate tests.
Discussion: We have designed a study that should be able to demonstrate whether the CDSS aimed at diagnostic
testing is not only able to influence appropriateness but also safe with respect to diagnostic error. These findings will
influence a lager, nationwide implementation of this CDSS.
Trial registration: ClinicalTrials.gov, NCT02950142.
Background
Laboratory testing is an important clinical act with a
valuable role in screening, diagnosis, management and
monitoring of diseases or therapies. Thirty percent of
patient contacts in primary care result in ordering one
or more laboratory tests [1, 2]. With 370 million tests
annually, laboratory testing is the most frequent medical
activity in Belgium [3]. There is a large variation in the
appropriateness of these orders [4–7]. Inappropriate la-
boratory test ordering has been estimated to be as high
as 30% [8, 9]. Besides the burden this poses on health
care spending, it also negatively influences quality of
care. Inappropriate tests may also result in false-positive
results and potentially cause excessive downstream
activities. Downstream or cascade activities are those
medical acts which result from altered or deviant tests.
This phenomenon is often referred to as the Ulysses
effect, and it is generally assumed that the effects of
inappropriate test ordering are larger on the downstream
activities than on the tests themselves [10]. To date, little
research has been done on these cascades and the true
extent of this Ulysses effect in primary care remains
unclear [11].
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Education-based interventions, feedback-based inter-
ventions and clinical decision support systems (CDSSs)
have shown promising results to influence the test-
ordering behaviour of physicians and to improve appro-
priateness [1, 9, 12, 13]. These findings, however, tend
not to be generalisable because many studies either
focus on very limited indications or measure testing vol-
ume rather than appropriateness. Order sets, a form of
CDSS where a limited set of evidence-based tests are
proposed for a series of indications, integrated in a com-
puterised physician order entry (CPOE) have been
shown to be effective in reducing the volume of ordered
laboratory tests [14, 15]. However, good evidence that
the use of order sets aimed at multiple indications im-
proves the appropriateness of laboratory test ordering is
still lacking. A barrier to adhering to evidence-based
policy is the fear for missing important pathology and
the liability this may create [2]. There is currently no
evidence that increasing appropriateness of laboratory
testing influences morbidity through diagnostic error or
delay. The aim of this study is to evaluate the effect of
order sets on the quality and quantity of laboratory test
orders by physicians. We also aim to evaluate the effect
of order sets on diagnostic error and explore the effect
on downstream or cascade activities.
Methods
Trial design
To evaluate this intervention, we will conduct a cluster
randomised controlled trial in Belgian primary care prac-
tices. The participants will be general practitioners (GPs)
working in primary care practices (PCPs) affiliated to
one of three collaborating laboratories in the Leuven,
Ghent or Antwerp regions. Currently, these laboratories
are starting to implement web-based CPOEs integrated
in the electronic health record (EHR) of primary care
physicians.
Participants
PCPs will be considered eligible if all the physicians
active in the practice agree to be involved in the study.
All physicians will be considered eligible if they:
 Collaborate with either one of three collaborating
laboratories: Medisch Centrum Huisartsen (MCH),
Anacura or Algemeen Medisch Laboratorium
(AML)
 Agree to use the online CPOE for their laboratory
test orders
 Use a computerised EHR for patient care
 Have little or no experience in the use of order sets
within a CPOE
 Agree to the terms in the clinical study agreement
We will aim our recruitment primarily at GPs with no
prior experience in the use of order sets. The rationale
for this exclusion criterion is that GPs who already use
some form of order sets will not stop doing so if they
were to be allocated to the control group. Experience in
the use of a CPOE will not be an exclusion criterion as
we wish to include GPs with varying experience in the
use of IT.
No GPs will be excluded on other grounds than the
above. Age, demographics, prior use of a CPOE (without
the use of order sets), prior laboratory ordering behaviour,
etc. will not be used to exclude eligible GPs. This will
provide us with a real-life, representative subset of GPs.
Interventions
Currently, most laboratory test orders are done through
a paper-based system. GPs request or take a blood sam-
ple from a patient, order tests manually on a paper form
by ticking boxes next to each test, manually add the pa-
tient contact detail to the form and send both the form
and the test tubes in a plastic bag to the laboratory.
Slowly, ambulatory laboratories in primary care have
started adopting CPOEs for ordering laboratory tests.
CPOEs have several benefits for both laboratories and
GPs. They reduce mistakes during the pre-analytical
phase, improve timeliness of reporting, reduce mistakes
during additional orders on the same sample and reduce
the overall turnaround time of samples [16, 17]. The
adoption of CPOEs also provides perspectives in
providing CDSS through order sets.
We will use two different types of CPOE in our study:
1. Lab Online (Moonchase) implemented at AML and
MCH and
2. E-Lab implemented at Anacura
Both systems are online platforms that allow the or-
dering of laboratory tests and the review of lab results
through a web-based interface. They are linked to the
EHR and integrate patient contact details through an Ex-
tensible Markup Language (XML) message. To date, no
patient-specific medical data is shared between the EHR
and the CPOE. When a physician initiates a laboratory
test order through the EHR, a web browser is opened
which allows the physician to order laboratory tests.
Currently, users are guided to an overview of commonly
used laboratory tests, very much like a paper-based
form. In our intervention, physicians will be prompted
to enter the indication(s) for ordering laboratory tests
through a searchable drop-down menu of common indi-
cations or a list of indications which can be selected
through tick boxes. Selecting one or more of these indi-
cations will prompt a new window which shows the ap-
propriate tests for these indications. In this window, the
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user will be able to accept the panel without changes, to
cancel one or more of the ordered test or to order
additional tests. The user will not be restricted in order-
ing any tests but will be ‘nudged’ in the direction of
ordering only the appropriate tests.
We developed a series of order sets based on recom-
mendations available through the EBMPracticeNet plat-
form [18]. We chose this database because it contains
context-specific guidelines on more than 1000 conditions
or situations including guidelines from the Flemish College
of Family Physicians on the laboratory testing for 20 differ-
ent indications commonly seen in general practice [19–21].
From these guidelines, we extracted recommendations on
17 common indications for investigation in this trial. These
order sets were translated into decision support rules that
suggest a panel of recommended tests when the physician
records the indications or conditions for testing.
Implementation
To maximise the effects of our intervention, we planned an
implementation strategy using the GUIDES checklist as a
reference [22]. We conducted interviews and panel meet-
ings with clinical biologists and information technologists
to validate the usability of each order set. We conducted
focus group interviews with GPs to identify barriers and fa-
cilitators to the use of our intervention in daily practice and
used these findings to tailor our intervention where feasible.
Currently the intervention is being tested in three GP prac-
tices and evaluated for usability and acceptability. At the
end of the trial, all participating GPs will be surveyed to
identify remaining factors that may have influenced its use.
Outcomes
Primary outcome
The definition of (in)appropriateness is broad and can
be interpreted in various ways. In this study, we will use
a restrictive definition for appropriateness where a test is
considered inappropriate if there is no clear indication
for ordering the test [8]. For instance, if, for condition A,
five tests are considered appropriate, then all additional
tests are considered inappropriate. We will also consider
a test inappropriate if it is underutilised or not ordered
within a certain time frame for a given condition. For in-
stance, if, for condition A, a test X is considered appro-
priate if it is ordered once per year, then all missing tests
X in that year will be considered inappropriate.
Secondary outcomes
Due to the role of the GP as a gateway keeper, caring for a
variety of complex patients, he is vulnerable to diagnostic
errors [23]. Diagnostic errors are defined as diagnoses that
were unintentionally delayed, wrong or missed [24]. In a
classification of diagnostic error, amongst the most im-
portant reasons for diagnostic error in laboratory testing
were the failure or delay in ordering needed tests and or-
dering of the wrong tests [25]. Despite the vulnerability of
primary care for diagnostic error, incidences remain low.
Very little reliable figures on diagnostic error due to la-
boratory testing exist, but several studies estimate it less
than 0.1 to 2.5% [26, 27]. An important concern in the in-
terpretation of these results lies in the fact that they are
often based on retrospective analyses with hindsight bias
[28]. Despite these apparently low figures, fear of diagnos-
tic error (and the related liability) is an important concern
for physicians when ordering laboratory tests [2]. Our sec-
ondary aim is to demonstrate that improving appropriate-
ness of laboratory testing does not result in more
diagnostic errors.
We will define diagnostic error as a diagnosis that was
unintentionally delayed (sufficient information was
available earlier), wrong (another diagnosis was made
before the correct one) or missed (no diagnosis was
made), in accordance with the definition of diagnostic
error by Graber et al. [24]. Our order sets recommend
tests for initial testing (when a condition or disease is sus-
pected) or for monitoring (when a condition or disease has
been diagnosed, but follow-up for the early detection of po-
tential side-effects of treatment or to monitor the evolution
of the condition is warranted). In both situations, the po-
tential for diagnostic error is present. We present some ex-
amples of diagnostic error in the Appendix.
Measuring this outcome is a challenge. We will use a
stepped approach, combining physicians’ reporting of
events, chart review and direct patient interviews of a
sample of patients. The rationale for adding patient in-
terviews is that some diagnostic errors do not result in
additional visits, further investigations or change in prac-
tice and will not be recorded in the EHR. Interviewing
the patient is the only way to detect these diagnostic er-
rors. The outcome will be measured as the number of
diagnostic errors in each arm.
We will also evaluate the effect of evidence-based
order sets on test volume. Inappropriateness is not only
a result of overutilisation but also of underutilisation,
and improving appropriateness may not necessarily re-
sult in reducing test volume [8]. We will measure this
outcome to contribute to this discussion. This outcome
will be measured as the number of tests ordered in each
arm for the 17 indications individually and for all labora-
tory tests ordered by physicians.
Exploratory outcomes
In a subset of 250 laboratory panels, we will review the
corresponding patient charts and identify all those activ-
ities originating directly from the results of the ordered
laboratory tests. We will use the methods by Houben et
al. [11] as a guide to identify those laboratory panels that
could potentially lead to downstream or cascade
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activities. We will focus on inappropriate tests in both
the control and intervention arm to evaluate the extent
of downstream activities and compare the difference in
downstream or cascade activities between abnormal and
normal results.
Sample size
Our study involves multiple levels of clustering which
are not independent of each other. Lowest on the level
of analysis is the individual laboratory test included in
our study. We must account for the fact that these tests
are not ordered entirely independent of each other in
one patient; for instance, a white blood cell count is
often ordered together with a white blood cell differenti-
ation. Additionally, there is clustering on the level of the
physician. When the same physician orders tests for
various patients over time, each of these orders is not in-
dependent of the other. For instance, if a physician often
requests chloride in patients taking diuretics, then this
will probably be so in all patients taking diuretics.
Finally, GPs often work in primary care practices.
Physicians working in the same practice tend to have
similar ordering behaviour implying that the orders
made by two physicians in the same practice are not
independent of each other. We therefore have a four
level clustering comprising test, patient, physician and
primary care practice with the following assumptions:
multiple study tests per patient, assumed to be 5 per pa-
tient; multiple patients per physicians, assumed to be 42
per 3 months if there is 70% use of the online interven-
tion [14]; and multiple physicians per primary care prac-
tice (PCP), assumed to be 2.35 [29].
Each of these clustering levels inflates the required
sample size [30]. Estimates of intracluster correlation co-
efficients (ICCs) for process of care measures in primary
care are between 0.05 and 0.15 [31, 32]; however, esti-
mates for ICCs regarding the appropriateness of labora-
tory tests have been shown to vary between 0.04 and
0.288 [33]. To our knowledge, no ICCs have been pub-
lished for clustering on the various levels observed in
our trial; therefore, we have chosen to use a very conser-
vative ICC estimate of 0.2 for each level of clustering in
our sample size calculations, probably overestimating
the design effect.
A trial with 80% power to detect a 10% difference in ap-
propriateness (in this case, from 70 to 80%) using a signifi-
cance level of 5% would require 586 tests in both arms.
Adjusting for the multi-level clustering inflates this to
7305 tests or 35 physicians in trial lasting 3 months.
We also aim to power our study to its secondary out-
come. Assuming 2.5% diagnostic errors in primary care,
we calculated that the trial, with an 80% power to detect
a non-inferiority of a 1% difference using a significance
level of 5%, would need 6032 patients in total. Previous
studies have illustrated that in primary care, ICCs for
clinical outcomes are lower than those for process out-
comes and the ICC for adverse effects to be around
0.025 [34]. Although this may not seem correct, the
chances that a physician consistently misses the same
diagnosis are less probable than consistently ordering
the same test for the same indication. Diagnostic error
will more probably lead to a change in practice than
over- or underutilisation of a laboratory test. For this
outcome, the unit of analysis is the individual patients and
not individual tests as for appropriateness, reducing clus-
tering with one level. Assuming a 3-month period in
which laboratory tests are ordered for 42 patients, we
would need to recruit 290 physicians. Our aim is to recruit
300 physicians, and it is expected that the trial will include
around 12,600 patients and a total of 63,000 tests.
Assignment of interventions
Randomisation of PCPs will be done using an electronic
random number generator blinded to the research facil-
ity. The research facility will be kept blinded to the allo-
cation, but collaborating laboratories will be able to
identify intervention and control PCPs. Allocation will
be kept blinded to all PCPs until the start of the study.
At the start of the study, GPs will be aware of the inter-
vention and their allocation to either the intervention or
control arm; however, patients and research facility will
be kept blinded to this allocation during the study and
until after the data analysis.
Data collection, management and analysis
The Scientific Institute for Public Health will facilitate
data collection and conform to privacy legislation
through the Healthdata platform. This platform allows
for secure, encrypted and pseudonomysed data transfer
from multiple sources into a central data warehouse.
Coded data from a single patient can be collected
through this system from more than one source. The
HD4DP (Healthdata for data providers) tool captures
the data from within the EHR or LIS (laboratory infor-
mation system) and allows the data provider to comple-
ment the tool with additional data which is not stored in
the EHR in a structured format. The source data re-
mains in the information system of the data provider,
and only an excerpt of this source data is transferred to
the platform. Data can be collected continuously or in a
one-time fashion depending on the resource. All data is
transferred through encrypted channels, using highly se-
cured national eHealth encryption algorithms. The re-
search facility can view the coded data using the
HD4RES (Healthdata for researchers) tool. The Scientific
Institute for Public Health will maintain the data ware-
house, including all coded data. The data warehouse is
highly secured, and access to the database is only
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possible through an extranet connection which does not
allow full access to the data. Only a small number of
members of the Scientific Institute for public Health are
authorised to access the full data. Figure 1 illustrates the
various phases of the trial including the data collection
points.
Baseline data to compare participating physicians will
be obtained at the start of the study. This data includes
the size of the PCP (how many active physicians), age of
the participating physician at the start of the study, sex
of the participating physician, number of active years in
general practice of the participating physician at the start
of the study, average number of tests per laboratory
order in the 3 months prior to the study and the level of
experience in the use of a CPOE prior to the study.
For comparisons of physician characteristics, compari-
sons will be made using generalised estimating equations
(GEEs), using PCP as the clustering variable. An inde-
pendent working correlation matrix will be used to ac-
count for correlations with the clusters. For continuous
variables, an identity link and normal distribution will be
used; for binary variables, a logit link and binary distri-
bution; and for categorical variables, a cumulative logit
link and multinomial distribution. Means and propor-
tions per group will be estimated from the model. For
the comparison of patient characteristics, similar meth-
odology will be used as for physician characteristics but
using the physician as the clustering variable.
Primary outcome analysis
To assess differences between the allocated groups in
the proportion appropriate tests, a logistic GEE model
will be used: of interest are the marginal proportions,
not the individual probabilities of the test to be
appropriate.
The logistic GEE model will include the allocated
group as a factor and patients as the clustering variable.
The effect of the intervention will be expressed as the
difference in proportions and will be presented together
with its associated 95% confidence interval. The propor-
tion of appropriate tests in the two allocated groups will
also be estimated from the GEE model and presented
with their 95% confidence intervals.
Appropriateness for the composite of all study tests
will be compared between the intervention and control
groups. Furthermore, an analysis will be performed that
only includes patients who have no indications in
addition to the 17 study indications. This additional ana-
lysis will correct for an overestimation of inappropriate
tests when more than one indication is selected, includ-
ing indications not under evaluation. These tests would
be considered inappropriate even though they could be
appropriate according to one of the other indications
not being evaluated. The analyses will be performed on
all patients from all physicians according to their
allocated group.
Secondary outcome analysis: diagnostic error
The proportion of patients with a missed diagnosis will
be analysed by means of a logistic GEE model that in-
cludes a factor for allocated group and uses PCP as the
clustering variable. An independent working correlation
matrix will be used. The proportion of patients with a
Fig. 1 Flow of the study including data collection points, assessments and reports. EHR: electronic health record
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missed diagnosis and associated 95% confidence
intervals will be estimated from the model.
The difference in proportions will be obtained by sub-
tracting the two proportions. The associated standard
error will be calculated from the rules for the variance of a
difference between two independent estimates. The 95%
confidence interval for the difference will be calculated.
The non-inferiority limit for missed diagnoses is 1%, i.e.
the intervention will be deemed non-inferior if the differ-
ence between the allocated groups (intervention − control)
is less than 1%. Therefore, the intervention will be deemed
non-inferior if the upper limit of the 95% confidence
interval lies below 1.
As for the primary endpoint, the analysis will be per-
formed for all 17 study indications together. An analysis
will be performed that only includes patients who have
no indications in addition to the 17 study indications.
Secondary outcome analysis: test volume and cascade
activities
The total number of tests and cascade activities will be
analysed using a Poisson GEE model that includes the
allocated group as the factor in the model and the
physician as the clustering variable. No offset will be
used. The number of tests per patient for each group
will be estimated from the model and presented together
with their associated 95% confidence intervals. The
effect of the intervention will be presented as the ratio
between the two numbers with its 95% confidence
interval. Statistical significance will be assessed at a
significance level of 5%.
Discussion
The effects of decision support have shown to be modest
and often inconsistent [35, 36]. Some of these CDSSs
have been implemented in settings not receptive to these
systems, lacked essential technical qualities or standards,
suffered from usability issues or were not trustworthy
enough [37, 38]. In this study, we used the insights in
the mechanisms that influence effectiveness of CDSS to
tailor our intervention where feasible. Moreover, the
potential for improvement is substantial with high rates of
inappropriateness. We developed 41 different order sets
(including sets with optional tests according to specific pa-
tient characteristics) for a total of 18 different indications.
The results of this study will reflect the true effect of a
CDSS in regular practice because we aim to include a
large sample of GPs with varying degrees of experience
in the use of a CPOE. We realise that an important fea-
ture critical to the success of our CDSS is the degree in
which physicians use the laboratory CPOE. In the tailor-
ing strategy for our study, we focussed on this issue and
aimed to improve the order sets in a fashion that would
make the care processes involved in ordering laboratory
tests more efficient. We will investigate any shortcom-
ings of our intervention at the end of the trial to further
improve its efficiency and effectiveness. Additionally, we
have designed a study that should be able to demon-
strate whether the CDSS aimed at diagnostic testing is
not only able to influence appropriateness but also safe
with respect to diagnostic error. More attention is being
focussed on patient safety as an important goal for
health care, and recommendations have been made on
implementing safety systems [39]. Our study will con-
tribute to the discussion on how CDSS systems can as-
sist not only in process of care but also in safe care.
These findings will influence a lager, nationwide imple-
mentation of this CDSS. These plans are facilitated by
the fact that most laboratories in Belgium use the same
software for their CPOE.
Appendix: examples of diagnostic error
Example of diagnostic error in initial testing (wrong test)
A physician suspects that his patient, who presented
with a swollen knee, suffers from an acute attack of gout.
He decides to test his patient for plasma uric acid to
confirm his suspicion. Plasma uric acid levels are
elevated, apparently confirming his suspicion, and he
prescribes the patient a non-steroidal anti-inflammatory
drug. Several days later, the patient returns with fever,
increased swelling of the knee and intensified pain. The
physician aspirates some synovial fluid and notices pus
in the sample. The patient did not suffer from a gout
attack but from a septic arthritis. A diagnostic aspiration
of synovial fluid would have diagnosed the condition
earlier.
Example of diagnostic error due to not testing
A female patient consults with general fatigue. The GP,
knowing that the patient has a stressful life, explains the
fatigue as a reaction to this stress. He considers labora-
tory testing not relevant in this case. A few months later
the patient is diagnosed with hypothyroidism.
Example of diagnostic error due to superfluous testing
A young adult patient consults because of decreased power
during his weekly football training. The GP performs a
laboratory test which shows increased Epstein-Barr anti-
bodies (EBV-IgG). The GP ascribes the complaints to a re-
covering mononucleosis infection and misses the real
reason for the complaints, which is overtraining. EBV-IgG
indicates an old infection and has no diagnostic value in
this case but led the GP to a wrong conclusion.
Example of diagnostic error in follow-up testing
A patient consults his physician for a yearly check-up of
hypertension for which he has been prescribed a thiazide
diuretic. The physician checks his blood pressure and
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finds it well controlled. He confirms the treatment and
prescribes refills without performing any laboratory
tests. Several weeks later, the patient consults the emer-
gency room because of a sudden syncope. In the hos-
pital, the physicians note that he suffers from a
hypokalaemia due to the thiazide treatment. This is an
example of a missed diagnosis that should have been
made during the yearly check-up of the hypertension
treatment.
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